Stem cell and exosome therapy for cerebral palsy in Istanbul, Turkey
Individualized Wharton's jelly MSC and exosome protocols utilizing intrathecal, intravenous, and intranasal routes, designed around neurological evaluations under Uzm. Dr. Cihan Bolat.
Understanding cerebral palsy and how neuro-regenerative biologics support neural repair
Cerebral palsy (CP) arises from an early insult to the developing brain that disrupts corticospinal motor pathways, basal ganglia circuits, and white-matter connectivity. While the initial perinatal injury itself does not progress, the surrounding brain tissue often remains locked in a state of chronic low-grade neuroinflammation, microglial overactivation, impaired oligodendrocyte myelin maintenance, and reduced synaptic plasticity. In daily life, these biological bottlenecks make it harder for surviving neural circuits to form efficient new connections—manifesting as muscle spasticity, dystonia, impaired trunk and head control, balance challenges, and slower gains during physical, occupational, or speech rehabilitation.
Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) and WJ-MSC-derived exosomes are designed to nourish and remodel this neural microenvironment across multiple biological fronts. Delivered via a tailored combination of intrathecal (cerebrospinal fluid), intravenous, and intranasal routes, WJ-MSCs secrete potent neurotrophic and angiogenic growth factors—including brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and VEGF—while shifting neurotoxic M1 microglia toward neuroprotective, reparative M2 phenotypes. Simultaneously, nanoscale WJ-MSC exosomes cross biological barriers to transfer regenerative microRNAs and synaptic-supportive proteins directly to neurons, astrocytes, and myelin-producing oligodendrocyte precursor cells—helping calm central neuroinflammation, support white-matter myelin integrity, and awaken latent neuroplasticity.
At our Istanbul clinic led by Uzm. Dr. Cihan Bolat, families begin by sharing neurological reports, brain MRI findings, and functional assessments. Our medical team designs an individualized multi-route protocol to work hand-in-hand with your ongoing home rehabilitation—aimed at easing spastic muscle tone, improving postural stability and motor coordination, and supporting communication and daily independence.
Reviewed by: Uzm. Dr. Cihan Bolat · Reviewed · Re-review due
What happens inside the body
What happens inside the nervous system in CP—and how WJ-MSCs and exosomes help repair it
Four interconnected neurobiological processes limit motor signaling and neuroplastic adaptation in cerebral palsy—each targeted directly by our multi-route cellular and exosome protocols.
Therapeutic objectives of our cerebral palsy protocol
Our neuro-regenerative protocols in Istanbul are designed to prime neuroplasticity and support neural repair signaling while the patient continues regular physical, occupational, and speech therapy at home.
Delivering neurotrophic growth factors (BDNF, GDNF, NGF, VEGF) to stimulate synaptic plasticity and axonal connectivity
Calming chronic central and systemic neuroinflammation by shifting microglia from M1 toward reparative M2 phenotypes
Supporting oligodendrocyte maturation, white-matter myelin integrity, and cerebral microvascular perfusion
Easing spastic muscle tone and supporting improvements in head/trunk control, balance, hand function, and speech coordination
Providing comprehensive medical documentation so home physiotherapy and neurology teams can build on the neuroplastic window
Early hypoxic-ischemic insult or periventricular leukomalacia (PVL) damages descending corticospinal motor fibers and basal ganglia circuits, interrupting smooth command signals from the motor cortex to the trunk and limbs.
WJ-MSCs and exosomes release high levels of BDNF, GDNF, and NGF along with angiogenic VEGF, supporting collateral axonal sprouting, nourishing perilesional neural networks, and improving microvascular blood flow to surviving motor regions.
Long after the initial birth injury, resident microglia and reactive astrocytes around damaged brain regions remain locked in a pro-inflammatory M1 state, releasing cytokines and free radicals that inhibit neural repair and synaptic growth.
Intrathecal and systemic WJ-MSCs and exosomes actively shift microglia from neurotoxic M1 states toward reparative, neuroprotective M2 phenotypes while expanding regulatory T cells, quieting the chronic neuroinflammation that stifles neuroplasticity.
In cerebral palsy, oligodendrocyte precursor cells (OPCs) often arrest before maturing into myelin-producing cells, leaving descending motor axons poorly insulated and slowing the speed and precision of electrical nerve conduction.
Exosomal microRNAs (such as the miR-17-92 cluster and miR-219) and paracrine trophic factors secreted by WJ-MSCs stimulate oligodendrocyte precursor differentiation and support myelin sheath repair across white-matter pathways.
04
Disrupted synaptic plasticity & hyperexcitable spastic tone
When descending inhibitory signals from the brain are weakened, spinal motor neurons become hyperexcitable—producing persistent muscle spasticity, involuntary dystonic posturing, co-contraction of opposing muscles, and exhausting physical stiffness.
By supporting synaptogenesis, enhancing inhibitory GABAergic/neurotrophic balance, and improving central-to-peripheral signaling efficiency, WJ-MSCs and exosomes help ease spastic muscle tone and make voluntary movement patterns more responsive to physical rehabilitation.
Why regenerative medicine is investigated
Scientific rationale for Wharton's jelly MSCs and exosomes
Biological repair rationale
Unlocking neuroplasticity around injured motor networks
Even after an early hypoxic, ischemic, or inflammatory brain injury, the developing and young nervous system retains remarkable reserve circuitry around the affected zones. However, chronic microglial inflammation, astrocytic scarring, and insufficient trophic growth factors prevent surviving neurons and oligodendrocytes from myelinating axonal tracts and forging strong compensatory synapses.
Neuro-regenerative therapy with WJ-MSCs and exosomes is investigated specifically to transform this hostile, inflamed neural milieu into a growth-permissive environment where physical and occupational therapy can drive stronger synaptic wiring.
Synergistic cellular & vesicular action
How WJ-MSCs and exosomes nourish neurons and myelin
Pairing Wharton's jelly MSCs with concentrated WJ-MSC-derived exosomes unites sustained paracrine neurotrophic release with rapid intracellular signaling. Live WJ-MSCs introduced into the cerebrospinal fluid or circulation secrete BDNF, GDNF, NGF, and VEGF—factors essential for axonal sprouting, cerebral microcirculation, and oligodendrocyte maturation—while calming pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6).
In parallel, nanoscale exosomes readily penetrate neural tissue to deliver neuroprotective microRNAs that support mitochondrial energy in stressed neurons, enhance synaptic vesicle cycling, and protect developing white-matter tracts.
Individualized clinical planning
Multi-route protocols customized to age, MRI, and clinical profile
Every child or adult with cerebral palsy has a unique neurological signature—defined by motor subtype (spastic, dyskinetic, ataxic, or mixed), GMFCS functional level, brain MRI pattern, and seizure history. Before your family travels to Istanbul, Uzm. Dr. Cihan Bolat's team thoroughly evaluates these records.
We then customize the exact weight-based cell and exosome dosages, select the appropriate combination of intrathecal (with or without sedation depending on clinical circumstances), intravenous, and intranasal routes, and establish concrete functional goals alongside your home therapy team.
Our treatment approach & administration routes
Our cerebral palsy biologics and administration routes
To reach both the central nervous system and systemic neuro-immune pathways, our medical team combines up to four targeted administration routes depending on the patient's clinical evaluation.
01
Intrathecal Wharton's Jelly MSC Administration
Intrathecal administration delivers GMP-prepared Wharton's jelly MSCs directly into the cerebrospinal fluid (CSF) via lumbar puncture, completely bypassing the blood-brain barrier. Once inside the CSF, the cells circulate along the spinal cord and cerebral subarachnoid space, releasing neurotrophic factors (BDNF, GDNF, NGF) and anti-inflammatory cytokines directly to injured motor tracts, microglia, and oligodendrocytes.
Role in your protocolPerformed under specialist medical supervision with or without sedation depending on the patient's age, muscle tone, comfort, and clinical circumstances.
02
Intravenous Wharton's Jelly MSC Infusion
Systemic intravenous WJ-MSC infusion modulates the peripheral neuro-immune axis—calming circulating pro-inflammatory cytokines, shifting systemic monocytes/macrophages toward reparative M2 states, and releasing angiogenic and trophic signals that support systemic vascular health and muscle tissue vitality.
Role in your protocolCell dosage is calculated precisely by body weight in kilograms and paired with central delivery routes for comprehensive neuro-immune support.
03
Intravenous WJ-MSC Exosome Administration
Intravenous WJ-MSC-derived exosomes deliver billions of nanoscale extracellular vesicles carrying neuroprotective microRNAs, growth factors, and metabolic-supportive proteins. Because exosomes measure only 30–150 nanometers, they readily cross microvascular barriers to nourish both peripheral neuromuscular junctions and central neural networks.
Role in your protocolPaired with live-cell infusions to unite rapid intracellular vesicular uptake with prolonged cellular paracrine secretion.
04
Intranasal WJ-MSC Exosome Administration
Non-invasive intranasal exosome administration delivers concentrated WJ-MSC exosomes onto the upper nasal mucosa, targeting the olfactory and trigeminal neural pathways as a direct nose-to-brain signaling route alongside intrathecal and intravenous administration.
Role in your protocolWhile preclinical and early clinical studies support nose-to-brain transport along olfactory and trigeminal nerves, we note transparently that the exact fraction of intranasal exosomes reaching human brain tissue remains under active study.
What we aim to achieve
How we track neuroplastic repair and functional milestones
Before treatment in Istanbul, we review the patient's baseline motor, tone, and daily participation profile so families and home therapists can track how biological neural support translates into concrete functional milestones over three, six, and twelve months.
01
Gross & fine motor control (GMFM milestones)
As neurotrophic factors (BDNF, GDNF) and oligodendrocyte myelin support strengthen descending motor pathways, families and physiotherapists track practical gains in head and neck stability, trunk posture, independent sitting, standing balance, gait pattern, and purposeful hand grasp.
02
Muscle tone relaxation & spasticity comfort
Calming central neuroinflammation and improving descending inhibitory balance often manifests first as smoother, more relaxed muscle tone. Families frequently monitor reductions in limb rigidity, scissoring, or involuntary spasms—making daily dressing, orthotic wear, positioning, and restful sleep noticeably more comfortable.
Synaptic remodeling across cortical and bulbar networks aims to support more than limb movement alone. Over longitudinal follow-up, we track improvements in visual tracking, alertness, social interaction, vocalization volume, speech articulation, and safer chewing and swallowing coordination.
04
Enhanced responsiveness to home rehabilitation
Biological therapy is designed to open a heightened window of neuroplasticity. Families and home physical, occupational, and speech therapists often observe that exercises and motor tasks that previously plateaued become easier for the child or adult to learn, retain, and build upon in the months following the Istanbul protocol.
How treatment is personalized
How our 6-step cerebral palsy evaluation works
Families begin by sending neurological reports, brain MRI findings, and functional assessments (or short movement videos). Our medical team under Uzm. Dr. Cihan Bolat evaluates the case, designs an individualized multi-route WJ-MSC and exosome protocol where appropriate, and explains the routes, sedation options, objectives, and costs before you travel to Istanbul.
Medical history & reports we request
Neurological diagnosis summary, CP subtype (spastic, dyskinetic, ataxic, or mixed), and GMFCS level
Brain MRI reports or images and birth/perinatal medical history
Seizure history, EEG reports if applicable, and current anti-epileptic or anti-spasticity medications
Swallowing, nutrition, respiratory, and orthopedic (hip or spine) history
Summary of current physical, occupational, and speech therapy goals
Clinical suitability & timing checks
Active, uncontrolled status epilepticus or rapidly escalating seizure frequency until neurologically stabilized
Active respiratory, urinary, or systemic infection or unexplained fever
Contraindications to lumbar puncture (such as elevated intracranial pressure or local spinal infection) for the intrathecal component
Acute cardiorespiratory instability making air travel or sedation unsafe
What the patient journey looks like
From your first inquiry to individualized treatment in Istanbul
Reach out regarding your condition and share your medical history, diagnosis, imaging, and relevant lab reports via our secure form or WhatsApp.
02
Medical team evaluation & protocol design
Our medical team evaluates your records and, where clinically appropriate, develops an individualized Wharton's jelly MSC and exosome protocol.
03
Transparent explanation of protocol & costs
We explain the proposed treatment, specific biologics, administration routes, intended therapeutic objectives, stay timeline, and itemized costs.
04
Arrange treatment in Istanbul & follow-up
Review your individualized proposal, schedule your visit to Istanbul with private airport and clinic transfers, and continue with structured 1, 3, and 6-month follow-up.
2026 cost & protocol planning
Cerebral palsy stem cell and exosome therapy cost in Istanbul
Once our medical team reviews your neurological and medical records, you receive a clear, itemized written protocol detailing the recommended intrathecal WJ-MSCs, intravenous WJ-MSCs, intravenous and intranasal WJ-MSC exosomes, sedation options if required, clinical monitoring, and total cost.
For context, our 2026 multi-route Wharton's jelly MSC and exosome programs generally range from $7,000 to $18,000 depending on body weight, cell and exosome dosage, administration routes, and number of sessions.
Combination of routes: intrathecal WJ-MSCs, intravenous WJ-MSCs, IV exosomes, and intranasal exosomes
Weight-adjusted cell count and total exosome concentration across the protocol
Whether intrathecal administration is performed with or without sedation based on clinical circumstances
Pre-treatment laboratory checks, clinical observation, and accessible VIP family transfers in Istanbul
Why does our protocol combine intrathecal, intravenous, and intranasal administration routes?
02
Will intrathecal WJ-MSC administration be performed with or without sedation for my child?
03
How many days will our family need to stay in Istanbul for the complete protocol?
04
How should we coordinate our home physical and occupational therapy after returning from Istanbul?
Evidence & important considerations
Published clinical trials in pediatric cerebral palsy research
Controlled pediatric trials and systematic reviews evaluate how umbilical cord and mesenchymal cell protocols interact with intensive rehabilitation to influence gross motor function.
Randomized, placebo-controlled study, 63 children with CP
Finding
Confirmed clinical safety; while overall mean GMFM-66 change did not differ across the full cohort, children receiving higher threshold cell doses demonstrated greater motor connectivity and GMFM-66 gains.
Limitation
Dose-dependent findings were exploratory, and functional progress remained closely linked to ongoing physical rehabilitation.
Mesenchymal and umbilical cord cell protocols across routes
Study design
Meta-analysis of controlled clinical studies in cerebral palsy
Finding
Reported positive adjunctive trends in Gross Motor Function Measure (GMFM) scores and muscle tone when combined with rehabilitation, alongside a favorable safety profile.
Limitation
Study heterogeneity in cell dose, administration route (intrathecal vs. IV), and baseline GMFCS level means individual outcomes vary.
Each route targets a distinct pathway: intrathecal WJ-MSC administration places cells directly into the cerebrospinal fluid to bypass the blood-brain barrier and support central neurotrophic signaling; intravenous WJ-MSCs modulate systemic neuro-immune inflammation; intravenous exosomes deliver nanoscale signaling cargo systemically; and intranasal exosomes target olfactory and trigeminal nose-to-brain pathways (noting transparently that the exact fraction reaching human brain tissue remains under study).
Request Free Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.
